Free Trial

Zimmer Biomet (ZBH) Competitors

Zimmer Biomet logo
$109.65 +0.71 (+0.66%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ZBH vs. GEHC, PHG, SOLV, SNN, PEN, GKOS, STVN, BLCO, INSP, and NARI

Should you be buying Zimmer Biomet stock or one of its competitors? The main competitors of Zimmer Biomet include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry.

Zimmer Biomet vs.

GE HealthCare Technologies (NASDAQ:GEHC) and Zimmer Biomet (NYSE:ZBH) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, community ranking, profitability, valuation and risk.

GE HealthCare Technologies has higher revenue and earnings than Zimmer Biomet. Zimmer Biomet is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GE HealthCare Technologies$19.55B1.98$1.57B$3.6423.28
Zimmer Biomet$7.39B2.95$1.02B$5.2620.85

Zimmer Biomet has a net margin of 14.27% compared to GE HealthCare Technologies' net margin of 8.56%. GE HealthCare Technologies' return on equity of 25.19% beat Zimmer Biomet's return on equity.

Company Net Margins Return on Equity Return on Assets
GE HealthCare Technologies8.56% 25.19% 5.93%
Zimmer Biomet 14.27%12.95%7.55%

GE HealthCare Technologies has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

Zimmer Biomet received 878 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. Likewise, 67.16% of users gave Zimmer Biomet an outperform vote while only 57.89% of users gave GE HealthCare Technologies an outperform vote.

CompanyUnderperformOutperform
GE HealthCare TechnologiesOutperform Votes
22
57.89%
Underperform Votes
16
42.11%
Zimmer BiometOutperform Votes
900
67.16%
Underperform Votes
440
32.84%

GE HealthCare Technologies pays an annual dividend of $0.12 per share and has a dividend yield of 0.1%. Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 0.9%. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Zimmer Biomet pays out 18.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, Zimmer Biomet had 1 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 13 mentions for Zimmer Biomet and 12 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.15 beat Zimmer Biomet's score of 0.85 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GE HealthCare Technologies
10 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Zimmer Biomet
7 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

GE HealthCare Technologies currently has a consensus price target of $96.00, indicating a potential upside of 13.29%. Zimmer Biomet has a consensus price target of $123.33, indicating a potential upside of 12.47%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe GE HealthCare Technologies is more favorable than Zimmer Biomet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GE HealthCare Technologies
1 Sell rating(s)
4 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.67
Zimmer Biomet
2 Sell rating(s)
11 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.25

82.1% of GE HealthCare Technologies shares are held by institutional investors. Comparatively, 88.9% of Zimmer Biomet shares are held by institutional investors. 0.3% of GE HealthCare Technologies shares are held by company insiders. Comparatively, 0.7% of Zimmer Biomet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

GE HealthCare Technologies beats Zimmer Biomet on 11 of the 21 factors compared between the two stocks.

Get Zimmer Biomet News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZBH vs. The Competition

MetricZimmer BiometSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$21.83B$10.16B$5.36B$19.88B
Dividend Yield0.92%1.42%5.13%3.70%
P/E Ratio20.8518.8889.4741.44
Price / Sales2.9525.591,253.3217.17
Price / Cash8.6122.0443.7519.84
Price / Book1.835.685.325.73
Net Income$1.02B$182.72M$122.60M$993.95M
7 Day Performance4.96%1.15%0.87%3.21%
1 Month Performance3.58%5.88%4.80%5.20%
1 Year Performance-11.42%-6.37%27.90%19.33%

Zimmer Biomet Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZBH
Zimmer Biomet
4.6618 of 5 stars
$109.65
+0.7%
$123.33
+12.5%
-10.3%$21.83B$7.39B20.8518,000News Coverage
GEHC
GE HealthCare Technologies
3.4105 of 5 stars
$85.32
+0.7%
$96.00
+12.5%
+16.5%$38.98B$19.56B23.4450,000Ex-Dividend
News Coverage
Positive News
PHG
Koninklijke Philips
3.396 of 5 stars
$25.61
-0.8%
N/A+11.0%$24.07B$18.04B-60.9778,200
SOLV
Solventum
0.3859 of 5 stars
$68.27
+1.8%
$68.29
+0.0%
N/A$11.79B$8.26B0.0022,000
SNN
Smith & Nephew
1.8426 of 5 stars
$23.99
+0.2%
N/A-7.6%$10.49B$5.64B12.2418,452
PEN
Penumbra
4.0141 of 5 stars
$244.42
-2.5%
$258.00
+5.6%
+2.7%$9.38B$1.16B284.214,200Positive News
GKOS
Glaukos
3.5852 of 5 stars
$153.04
-2.2%
$147.75
-3.5%
+75.2%$8.44B$360.35M-50.68780Short Interest ↑
STVN
Stevanato Group
N/A€22.29
-2.8%
N/A-16.2%$6.59B$1.09B47.435,635Gap Up
BLCO
Bausch + Lomb
2.9344 of 5 stars
$17.30
-2.6%
$20.58
+19.0%
+18.0%$6.09B$4.68B-16.4813,300Analyst Forecast
INSP
Inspire Medical Systems
4.8422 of 5 stars
$179.10
-11.5%
$233.58
+30.4%
-5.2%$5.37B$755.59M167.381,011High Trading Volume
NARI
Inari Medical
1.5398 of 5 stars
$79.35
+0.1%
$68.00
-14.3%
+36.7%$4.65B$574.50M-58.78800

Related Companies and Tools


This page (NYSE:ZBH) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners